Physician profile
Nabil Sabbak
NPI 1225492119
$13,926.94
in general payments reported to CMS, 2019-2025
13 companies · $8,655 in 2025
The $8,655 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $793 · 2023: $2,106 · 2024: $2,373 · 2025: $8,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,582 · Travel and Lodging: $5,051 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,582.35 |
| Travel and Lodging | $5,051.21 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,686.60 | 2023-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $4,239.26 | 2022-2025 | Vitalyst, Watchman Flx, Rotapro |
| Abbott Laboratories | $2,568.83 | 2023-2025 | Mitraclip, Amplatzer, Portico |
| Medtronic, INC. | $706.29 | 2022-2025 | Symplicity G3, Hawkone, Micra |
| Cardiovascular Systems INC. | $288.62 | 2022-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $240.50 | 2022-2025 | |
| Cardiva Medical, INC. | $64.23 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| W. L. Gore & Associates, INC. | $48.07 | 2024-2025 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.99 | 2025 | Lifevest |
| Amgen INC. | $21.61 | 2025 | Repatha |
| Philips North America LLC | $20.98 | 2022 | |
| Biotronik INC. | $16.96 | 2023 | Pk Papyrus, Orsiro Mission |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Sabbak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.